| | | | | |
AVTX Avalo Therapeutics, Inc. Common Stock | €11,8139 | -1,79% | €722,46M | €1,20M | |
| €40,0001 | -3,11% | €722,04M | €111,30K | |
| €17,3202 | +1,41% | €720,99M | €217,25K | |
EVC Entravision Communication | €7,1952 | -7,33% | €720,13M | €1,51M | |
ETON Eton Pharmaceutcials, Inc. Common Stock | €23,8045 | +0,82% | €718,74M | €252,61K | |
| €22,2620 | -3,80% | €717,12M | €113,25K | |
AMPH Amphastar Pharmaceuticals, Inc. | €15,6054 | -1,84% | €716,20M | €331,33K | |
MATW Matthews International Corp | €21,9173 | -2,55% | €713,58M | €174,29K | |
TBPH Theravance Biopharma, Inc. | €13,7096 | +2,12% | €713,43M | €228,03K | |
MPB Mid Penn Bancorp, Inc. | €27,1608 | -4,14% | €713,06M | €126,05K | |
KRO Kronos Worldwide, Inc. | €5,9716 | -4,15% | €712,82M | €127,03K | |
ADAM Adamas Trust, Inc. Common Stock | €7,5657 | -2,98% | €712,38M | €443,09K | |
CAPL CrossAmerica Partners LP Common units representing limited partner interests | €18,8626 | -0,23% | €710,81M | €18,47K | |
ROOT Root, Inc. Class A Common Stock | €45,0928 | -6,08% | €709,96M | €194,68K | |
EOI Eaton Vance Enhanced Equity Income Fund | €17,0530 | -0,75% | €709,45M | €49,33K | |
